1-13 of 13
William T Johnson
Close
Sort by
Journal Articles

Emapalumab for Malignancy-Associated Hemophagocytic Lymphohistiocytosis: The Memorial Sloan Kettering Cancer Center Experience

William T. Johnson, Zachary D. Epstein-Peterson, Nivetha Ganesan, Tiffany Chang, Natasha Galasso, Robert Stuver, Niloufer Khan, Gilles Salles, Alison J. Moskowitz, Santosha Vardhana, Steven M. Horwitz
Journal: Blood
Blood (2022) 140 (Supplement 1): 3704–3706.
https://doi.org/10.1182/blood-2022-168063
Published: 2022
Journal Articles

Characterization of a Large Cohort of Patients with Nodal Marginal Zone Lymphoma Shows Prolonged Survival, Time-to-Treatment, and Time-to-Transformation

Robert Stuver, Esther Drill, David Qualls, Michelle Okwali, Connie Lee Batlevi, Philip C Caron, Zachary D. Epstein-Peterson, Lorenzo Falchi, Audrey Hamilton, Paul A. Hamlin, Steven M. Horwitz, Andrew M. Intlekofer, William T. Johnson, Niloufer Khan, Oscar B Lahoud, Jennifer Kimberly Lue, Matthew J. Matasar, Alison J. Moskowitz, Ariela Noy, M.Lia Palomba, Santosha Vardhana, Andrew D. Zelenetz, Gilles Salles, David J. Straus
Journal: Blood
Blood (2022) 140 (Supplement 1): 9380–9382.
https://doi.org/10.1182/blood-2022-156383
Published: 2022
Journal Articles

Outcomes for Patients with Relapsed and Refractory Peripheral T-Cell Lymphoma in the 21 st Century By Relapse Status, Salvage Therapy, and Receipt of Allogeneic Transplant

Robert Stuver, Zachary D. Epstein-Peterson, William T. Johnson, Niloufer Khan, Craig S. Sauter, Michael Scordo, Gunjan L. Shah, Alison J. Moskowitz, Steven M. Horwitz
Journal: Blood
Blood (2022) 140 (Supplement 1): 3671–3672.
https://doi.org/10.1182/blood-2022-156384
Published: 2022
Journal Articles

Identifying Primary Refractory Disease and Early Relapses in Peripheral T-Cell Lymphoma Using Baseline Characteristics, Minimal Residual Disease, and Mutational Profiling

Robert Stuver, Harleigh Haynie, Zachary D. Epstein-Peterson, William T. Johnson, Niloufer Khan, Anita Mazloom, Alison J. Moskowitz, Esther Drill, Steven M. Horwitz
Journal: Blood
Blood (2022) 140 (Supplement 1): 3669–3670.
https://doi.org/10.1182/blood-2022-167608
Published: 2022
Journal Articles

Immune Signature of Pembrolizumab Plus Gemcitabine, Vinorelbine, and Liposomal Doxorubicin As Second-Line Therapy for Relapsed or Refractory Classical Hodgkin Lymphoma

Beatriz Wills, Nivetha Ganesan, Gunjan L. Shah, Phillip Wong, Kimon V. Argyropoulos, Filiz Sen, Ahmet Dogan, David J. Straus, Ariela Noy, Anita Kumar, Heiko Schoder, Laure Michaud, Maria Lia Palomba, Lorenzo Falchi, Oscar B Lahoud, Paul A. Hamlin, Joachim Yahalom, William T. Johnson, Andrew D. Zelenetz, Andrew M. Intlekofer, Colette Owens, Connie Lee Batlevi, Audrey Hamilton, Philip C Caron, Steven M. Horwitz, Natasha Galasso, Helen Hancock, Theresa Davey, Alayna Santarosa, Leslie Perez, Charisse Capadona, Brittney Munayirji, Matthew J. Matasar, Georgios Pongas, Ellie Casper, Gilles Salles, Craig H. Moskowitz, Santosha Vardhana, Alison J. Moskowitz
Journal: Blood
Blood (2022) 140 (Supplement 1): 9286–9288.
https://doi.org/10.1182/blood-2022-160206
Published: 2022
Journal Articles

Molecular Profiling across Lymphoma Subtypes Using MSK-Impact Next Generation Sequencing

Connie Lee Batlevi, Esther Drill, Michelle Okwali, Ryan Ptashkin, Philip C Caron, Zachary D. Epstein-Peterson, Lorenzo Falchi, Audrey Hamilton, Paul A. Hamlin, Steven M. Horwitz, Andrew M. Intlekofer, William T. Johnson, Niloufer Khan, Anita Kumar, Jennifer Kimberly Lue, Matthew J. Matasar, Alison J. Moskowitz, Ariela Noy, Colette Owens, Maria Lia Palomba, David J. Straus, Santosha Vardhana, Andrew D. Zelenetz, Maria E. Arcila, Ahmet Dogan, Venkatraman Seshan, Gilles Salles, Ahmet Zehir, Anas Younes
Journal: Blood
Blood (2022) 140 (Supplement 1): 9251–9253.
https://doi.org/10.1182/blood-2022-158783
Published: 2022
Journal Articles

Efficient Targeting of CD38 in Mature T-Cell Neoplasms with Daratumumab and Allogeneic NK Cells

William T. Johnson, Colleen Isabelle, Ashley N Vogel, Jonathan E Brammer, Amy E Boles, Kathleen McConnell, Robyn Berge, Liam Nisenfeld, Guldeep Uppal, Jerald Gong, Nitin Chakravarti, Pierluigi Porcu, Anjali Mishra
Journal: Blood
Blood (2021) 138 (Supplement 1): 2408.
https://doi.org/10.1182/blood-2021-154234
Published: 2021
Journal Articles

Interim Efficacy Analysis of a Phase II Study Demonstrates Promising Activity of the Combination of Pembrolizumab (PEM) and Entinostat (ENT) in Relapsed and Refractory (R/R) Hodgkin Lymphoma (HL)

David J. Sermer, Santosha Vardhana, Erin Biggar, Alison J. Moskowitz, Erel Joffe, Niloufer Khan, David J. Straus, Anita Kumar, Andrew D. Zelenetz, Steven M. Horwitz, Ariela Noy, Connie Lee Batlevi, Audrey Hamilton, Colette Owens, Matthew J. Matasar, M. Lia Palomba, Christina Y. Lee, Lorenzo Falchi, William T. Johnson, Heiko Schoder, Ahmet Dogan, Tira Bunyaviroch, Venkatraman Seshan, Gilles Salles, Anas Younes, Gottfried von Keudell
Journal: Blood
Blood (2021) 138 (Supplement 1): 2447.
https://doi.org/10.1182/blood-2021-154226
Published: 2021
Journal Articles

TP53 Mutations Identify High-Risk Peripheral T-Cell Lymphoma Patients Treated with CHOP-Based Chemotherapy

William T. Johnson, Nivetha Ganesan, Zachary D. Epstein-Peterson, Catherine Maccaro, Natasha Galasso, Craig S. Sauter, Rachel Neuman, Niloufer Khan, Alison J. Moskowitz, Ahmet Dogan, Steven M. Horwitz
Journal: Blood
Blood (2021) 138 (Supplement 1): 1367.
https://doi.org/10.1182/blood-2021-151779
Published: 2021
Journal Articles

Impact of Choice of Platinum-Based Salvage Therapy on CNS Relapse in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Michael J Buege, Phuong Dao, Raymond G Dematteo, Andréa LeVoir, Terry Pak, Connie Lee Batlevi, Audrey Hamilton, Paul A. Hamlin, Steven M. Horwitz, Erel Joffe, William T Johnson, Niloufer Khan, Anita Kumar, Christina Y. Lee, Matthew J. Matasar, Alison J. Moskowitz, Ariela Noy, Colette Owens, M. Lia Palomba, David J. Straus, Gottfried von Keudell, Andrew D. Zelenetz, Christian Grommes, Craig S. Sauter, Gilles Salles, Lorenzo Falchi
Journal: Blood
Blood (2021) 138 (Supplement 1): 2529.
https://doi.org/10.1182/blood-2021-147527
Published: 2021
Journal Articles

The EZ-riding NK/T-cell lymphoma

William T. Johnson, Anjali Mishra
Journal: Blood
Blood (2019) 134 (23): 1999–2000.
https://doi.org/10.1182/blood.2019003023
Published: 2019
Journal Articles

A Prospective Cohort of Black Patients with Mycosis Fungoides and Sézary Syndrome: Subset Analysis of the Mavoric Trial

William T Johnson, DO, Saritha Kartan, MD, Neda Nikbakht, MD PhD, Pierluigi Porcu, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4766.
https://doi.org/10.1182/blood-2019-126313
Published: 2019
Journal Articles

Outcomes of Methotrexate-Associated T-Cell and NK/T-Cell Lymphoproliferative Disorders in Patients with a History of Rheumatological Disorders: A Retrospective Analysis of EBV-Association and Response to MTX Withdrawal

William T Johnson, DO, Danielle Garfunkel, B.S., Misung Yi, Benjamin E Leiby, PhD, Saritha Kartan, MD, Pierluigi Porcu, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5347.
https://doi.org/10.1182/blood-2018-99-120070
Published: 2018